<DOC>
	<DOC>NCT02680262</DOC>
	<brief_summary>The trial will evaluate the effect on participation in organised screening programme of a human papilloma virus (HPV) self-sampling kit directly mailed home or mailed on demand compared with the standard second reminder for regular screening.</brief_summary>
	<brief_title>Self-sampling for Non-participants in an Organised Cervical Cancer Screening Programme</brief_title>
	<detailed_description>The CHOice trial is a parallel randomised controlled, open label trial. Participants will be equally randomised into three arms: 1) Directly mailed a second reminder including a HPV self-sampling kit; 2) Mailed a second reminder offering a HPV self-sampling kit, to be ordered by e-mail, by text message, by phone, or by website; and 3) Mailed a second reminder for a conventional practitioner-collected sample (control group).</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<criteria>Women resident in the Central Denmark Region who have not participate in cervical cancer screening after an invitation and one reminder Women younger than 30 years are not included due to the lower specificity of HPV DNA tests in younger women</criteria>
	<gender>Female</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>HPV self-sampling, cervical cancer screening</keyword>
</DOC>